Barra, M., Vaitkevicius, H., Husain, A., Raja, S., Macleod, D., Guptill, J., … Rybak, E. (2023). 814: PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS GANAXOLONE IN HEALTHY ADULT VOLUNTEERS. In Critical Care Medicine (Vol. 51, pp. 398–398). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/01.ccm.0000908984.89894.75

Barra, Megan, Henrikas Vaitkevicius, Aatif Husain, Shruti Raja, David Macleod, Jeff Guptill, Maciej Gasior, and Eva Rybak. “814: PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS GANAXOLONE IN HEALTHY ADULT VOLUNTEERS.” In Critical Care Medicine, 51:398–398. Ovid Technologies (Wolters Kluwer Health), 2023. https://doi.org/10.1097/01.ccm.0000908984.89894.75.

Barra M, Vaitkevicius H, Husain A, Raja S, Macleod D, Guptill J, et al. 814: PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS GANAXOLONE IN HEALTHY ADULT VOLUNTEERS. In: Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2023. p. 398–398.

Barra, Megan, et al. “814: PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS GANAXOLONE IN HEALTHY ADULT VOLUNTEERS.” Critical Care Medicine, vol. 51, no. 1, Ovid Technologies (Wolters Kluwer Health), 2023, pp. 398–398. Crossref, doi:10.1097/01.ccm.0000908984.89894.75.

Barra M, Vaitkevicius H, Husain A, Raja S, Macleod D, Guptill J, Gasior M, Rybak E. 814: PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS GANAXOLONE IN HEALTHY ADULT VOLUNTEERS. Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2023. p. 398–398.